SELLAS Life Sciences Group, Inc.
- Last sale
- Nov 12, 2026 · -4.58%
- Market cap
- $1.64B
- 203.86M shares
- Filings
- 1,010
Q3 2026−100.0% FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
FY 2016derivedN/M FY16 yoy
Q3 2026N/M FY25 yoy
Q3 2026+417.0% FY25 yoy
- $1.64B
- —
- —
- 12.4×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $1,000,000 | reported | |
| FY 2021 | 2021-12-31 | $7,600,000 | reported | |
| FY 2020 | 2020-12-31 | $1,900,000 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2014 | 2014-12-31 | $9,319,000 | reported | |
| FY 2013 | 2013-12-31 | $2,487,000 | reported | |
| FY 2012 | 2012-12-31 | $0 | reported | |
| FY 2011 | 2011-12-31 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2019 | $0.00 | — | $0.00 | — | 6.72M sh | −71.0% | — |
| FY2018 | $487.00K | — | $487.00K | — | 23.18M sh | +252.6% | — |
| FY2017 | $0.00 | — | $0.00 | — | 6.57M sh | −83.1% | — |
| FY2010 | — | $3.85M | $3.85M | — | 18.37M sh | — | — |
Pharmaceutical preparations
SELLAS Life Sciences Group, Inc. is the 109th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
STOKStoke Therapeutics, Inc.$184.4M404.5%3.7%$1.7BPGENPrecigen, Inc.$9.7M146.7%2,588.2%$1.7BADRXADARx Pharmaceuticals, Inc.———$1.7B
SLSSELLAS Life Sciences Group, Inc. (this company)———$1.6B
GENBGenerate Biomedicines, Inc.———$1.6BANIPANI Pharmaceuticals Inc$883.4M43.8%8.9%$1.6BNBTXNanobiotix S.A.———$1.6BETONEton Pharmaceuticals, Inc.$80.0M104.9%5.8%$1.6BRAREUltragenyx Pharmaceutical Inc.$673.0M20.2%85.4%$1.6BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR